ProgenityLogo.jpg
Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results
August 12, 2021 16:01 ET | Progenity, Inc.
Announced successful completion of the validation study PRO-104 for the Preecludia™ rule out test for preeclampsia and achievement of the primary endpoint of the study protocol Recently achieved...
ProgenityLogo.jpg
Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update
August 05, 2021 16:05 ET | Progenity, Inc.
SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report second quarter 2021 financial results on...
ProgenityLogo.jpg
Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primary Endpoint for its Preeclampsia Rule-Out Test
July 29, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today successful completion of the validation study for its Preecludia™...
ProgenityLogo.jpg
Progenity Announces Appointment of Surbhi Sarna to its Board of Directors
June 30, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Surbhi Sarna to its board of directors effective July...
ProgenityLogo.jpg
Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board
June 17, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the formation of its Inflammatory Bowel Disease Clinical Advisory...
ProgenityLogo.jpg
Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference
June 15, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, June 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that Harry Stylli, PhD, CEO, chairman of the board, and co-founder...
Shareholders Foundation
NASDAQ: PROG Investor Notice: Update in Lawsuit against Progenity, Inc. announced by Shareholders Foundation
June 15, 2021 07:10 ET | Shareholders Foundation, Inc.
SAN DIEGO, June 15, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is pending for certain investors in NASDAQ: PROG shares. Investors, who...
ProgenityLogo.jpg
Progenity Announces $40 Million Private Placement
June 10, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive securities...
ProgenityLogo.jpg
Progenity Launches Strategic Transformation into Biotech Company, Eliminating Costs of Progenity Genetics Lab and Focusing on Robust, Innovative R&D Pipeline
June 02, 2021 07:00 ET | Progenity, Inc.
Closure of genetics lab and other operational improvements expected to result in approximately 70% reduction of annual capital required for operations – from more than $180 million currently to...
ProgenityLogo.jpg
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
May 26, 2021 07:30 ET | Progenity, Inc.
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced results from a further study for the company’s Targeted Therapeutics...